AstraZeneca and Bristol-Myers Squibb Diabetes Alliance provides $5 million grant for American Diabetes Association’s Pathway to Stop Diabetes research initiative
16 January 2014 | By Bristol-Myers Squibb
Three-year commitment provides significant support for new generation of diabetes researchers...